Marley Spoon H1 2026 operating EBITDA turns to loss of €6.8 million; net revenue drops 24% to €105.6 million
Bitget2026/09/29 17:47- Marley Spoon reported H1 2026 net revenue of €105.6 million, down 24% year over year.
- Operating EBITDA swung to a loss of €6.8 million, with the operating EBITDA margin turning to -6% from 4%.
- Marketing expenditure rose to €21.1 million, equal to about 20% of net revenue, while general and administrative expenses fell to €30.4 million.
- FreshRealm filed for Chapter 11 reorganization on April 27, 2026, and Misfits Market became the US fulfillment and supply partner.
- For 2026, net revenue at constant currency is seen at €175 million-€185 million, with operating EBITDA forecast at a loss of €21 million-€17 million.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Starbucks (SBUX.US) officially refutes rumors: clearly denies acquiring Chipotle (CMG.US), focuses on "Back to Starbucks" transformation strategy
Starbucks publicly clarified on Monday that the company has not acquired Chipotle Mexican Grill, putting an end to the previous acquisition rumors.
BlackRock increases allocation to short-term US Treasuries and lowers US stocks: "Rate hike bets have gone too far," high yields should be prioritized
BlackRock has turned bullish on U.S. Treasury bonds for the first time in six years, upgrading short-term bonds to overweight and downgrading U.S. equities to neutral, stating that rate hike expectations are excessive and it is time to lock in yields.
AstraZeneca (AZN.US) Relizumab's new indication is expected to be included in priority review
Relizumab is a blockbuster product under AstraZeneca, with global sales projected to reach 4.718 billions USD in 2025 (YOY +20.23%).
4 Big Bank Earnings to Watch This Week as Wall Street Turns Bullish
Crypto prices
More
